Tocilizumab as treatment for COVID-19: A systematic review and meta-analysis

BACKGROUND: The majority of patients with coronavirus disease 2019 (COVID-19) have good prognoses, but some develop a critical illness that can lead to death. Evidence shows severe acute respiratory syndrome is closely related to the induced cytokine storm. Interleukin-6 is a key player; its role in...

Descripción completa

Detalles Bibliográficos
Autores principales: Petrelli, Fausto, Cherri, Sara, Ghidini, Michele, Perego, Gianluca, Ghidini, Antonio, Zaniboni, Alberto
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Baishideng Publishing Group Inc 2021
Materias:
Systematic Reviews
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8127418/
https://www.ncbi.nlm.nih.gov/pubmed/34026583
http://dx.doi.org/10.5662/wjm.v11.i3.95

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8127418/
https://www.ncbi.nlm.nih.gov/pubmed/34026583
http://dx.doi.org/10.5662/wjm.v11.i3.95

Ejemplares similares